Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Revenue | 62M | 42M |
| Research and development | 132M | 144M |
| Selling, general and administrative | 42M | 44M |
| Operating expenses | 174M | 188M |
| Operating income | −111M | −146M |
| Pre-tax income | −102M | −130M |
| Income tax | 4,000 | 208,000 |
| Net income | −102M | −130M |
| Earnings per share | −0.87 | −1.19 |
| Earnings per share, diluted | −0.87 | −1.19 |
| Weighted average shares | 116M | 109M |
| Weighted average shares, diluted | 116M | 109M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 158M | 112M | 58M | 39M | 58M | 70M | 53M | 52M |
| Short-term investments | 222M | 231M | 94M | 142M | 158M | 188M | 240M | 271M |
| Current assets | 392M | 354M | 164M | 190M | 225M | 266M | 301M | 328M |
| Property, plant and equipment | 6M | 7M | 7M | 8M | 8M | 8M | 9M | 9M |
| Total assets | 436M | 399M | 210M | 238M | 274M | 316M | 352M | 381M |
| Current liabilities | 14M | 22M | 18M | 40M | 36M | 38M | 38M | 44M |
| Total liabilities | 44M | 53M | 50M | 103M | 108M | 117M | 123M | 134M |
| Equity | 392M | 346M | 160M | 135M | 167M | 200M | 229M | 248M |
| Shares outstanding | 144M | 136M | 112M | 111M | 108M | 108M | 107M | 107M |
| Shares issued | 144M | 136M | 112M | 111M | 108M | 108M | 107M | 107M |
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Operating cash flow | −139M | −132M |
| Depreciation and amortisation | 2M | 2M |
| Share-based compensation | 26M | 29M |
| Capital expenditure | 1M | 754,000 |
| Investing cash flow | −41M | 86M |
| Financing cash flow | 223M | 48M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator